- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Sitravatinib
Total 38 results
-
BeiGeneCompletedCarcinoma, Hepatocellular | Gastric/Gastroesophageal Junction CancerChina
-
Mirati Therapeutics Inc.CompletedHepatic ImpairmentUnited States
-
BeiGeneCompleted
-
Mirati Therapeutics Inc.CompletedHealthy AdultsUnited States
-
Peking University Cancer Hospital & InstituteRecruiting
-
C. Kent Osborne, MDMirati Therapeutics Inc.WithdrawnBreast Neoplasms | Triple Negative Breast Cancer | Breast Cancer Stage IV | Breast Cancer MetastaticUnited States
-
BeiGeneWithdrawn
-
Matthew InghamMirati Therapeutics Inc.Active, not recruitingLiposarcoma | Metastatic LiposarcomaUnited States
-
Anhui Provincial HospitalHenan Cancer Hospital; First Affiliated Hospital Xi'an Jiaotong University; First...Recruiting
-
Mirati Therapeutics Inc.CompletedAdvanced CancerKorea, Republic of, United States
-
BeiGeneCompletedAdvanced Solid TumorsChina, Australia
-
Fudan UniversityTerminated
-
Zhejiang Cancer HospitalActive, not recruiting
-
Grupo Español Multidisciplinar de MelanomaMirati Therapeutics Inc.; BeiGeneActive, not recruiting
-
Seoul National University HospitalBeiGeneActive, not recruitingAdvanced Biliary Tract CancerKorea, Republic of
-
Haider MahdiMirati Therapeutics Inc.WithdrawnSolid Tumors | Recurrent Endometrial CancerUnited States
-
Australia New Zealand Gynaecological Oncology GroupBeiGeneWithdrawn
-
Mirati Therapeutics Inc.CompletedClear Cell Renal Cell CarcinomaUnited States
-
BeiGeneTerminatedNon-Small Cell Lung Cancer (NSCLC)China, Australia
-
Sarah GoldbergMirati Therapeutics Inc.TerminatedLung Diseases | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Metastatic Lung Non-Small Cell Carcinoma | PD-L1 Gene Mutation | Pembrolizumab | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Advanced Treatment-Naïve PD-L1 | SitravatinibUnited States
-
Mirati Therapeutics Inc.Active, not recruitingClear-Cell Renal Cell CarcinomaUnited States
-
Jun LiUnknown
-
Onze Lieve Vrouw HospitalTerminatedOne-Lung VentilationBelgium
-
Mirati Therapeutics Inc.TerminatedUrothelial Carcinoma Bladder | Urothelial Carcinoma | Urothelial Carcinoma Ureter | Urothelial Carcinoma of the Renal Pelvis and Ureter | Urothelial Carcinoma UrethraUnited States
-
University Health Network, TorontoMirati Therapeutics Inc.CompletedSquamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma, Head And Neck | Squamous Cell Carcinoma MouthCanada
-
Mirati Therapeutics Inc.TerminatedCarcinoma, Non-Small-Cell LungUnited States
-
Mirati Therapeutics Inc.Bristol-Myers SquibbActive, not recruitingMetastatic Non-Squamous Non-Small Cell Lung CancerUnited States, Canada, Belgium, France, Germany, Hungary, Israel, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
BeiGeneTerminatedEsophageal Squamous Cell CarcinomaChina
-
Mirati Therapeutics Inc.Enrolling by invitationAdvanced or Metastatic Solid MalignanciesUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingMetastatic Clear Cell Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8United States
-
Mirati Therapeutics Inc.Completed
-
Fudan UniversityActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Metastatic Kidney CarcinomaUnited States
-
University of BirminghamPfizer; AstraZeneca; Mirati Therapeutics Inc.; Cancer Research UK; Experimental Cancer...Active, not recruitingAdenocarcinoma | Carcinoma, Squamous Cell | Non-Small Cell Lung CancerUnited Kingdom
-
Mirati Therapeutics Inc.CompletedHealthy AdultsUnited States
-
BeiGeneEnrolling by invitationAdvanced MalignanciesChina, Taiwan, Korea, Republic of, Turkey
-
Clinical Research Centre, MalaysiaNot yet recruitingStaphylococcus Aureus BacteremiaMalaysia
-
Mirati Therapeutics Inc.CompletedAdvanced Solid TumorUnited States